MOUNTAIN VIEW, CA–Dec 4, 2008 — Broncus Technologies, Inc., a pharmaceutical device company developing products for emphysema and other lung diseases, announced today that it has closed a $38 million round of Series G funding, led by a $25 million investment fr…
Devices, Venture Capital
Broncus Technologies

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences”
Leave a Comment